Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Shasun Chemicals and Drugs Limited
Shasun Chemicals and Drugs Limited
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future
To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world,...
IMA Life and RheaVita team up to commercialise continuous biopharmaceutical freeze-drying tech
The companies will work in tandem to develop and commercialise its continuous freeze-drying technology, allowing the rapid production of complex biopharmaceuticals
Transmission Raman Spectroscopy - access the webinar series today
Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface...
Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site
The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
IMed supports K2 medical systems in their EU MDR transition
Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
Upcoming event
CPhI India
26–28 November 2024 | Online Conference & Networking | Delhi, India
See all
Related Content
Finance
Strides Shasun acquires three OTC brands from Moberg Pharma
Indian firm is building an over-the-counter drug franchise in regulated and emerging markets
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Ingredients
Indian API market on the up as domestic drug prices fall
Indian API manufacturers are branching out into new markets, while international suppliers could be hit by lower prices in the domestic market, writes Asia correspondent A Nair
Ingredients
Indian pharma exports to be hit by Falsified Medicines Directive
API exporters say latest EU move is a non-issue
Subscribe now